Highlights from the John Goldman Conference on CML 2019:
CML experts give their personal perspectives

Perspectives on the clinical aspects of the meeting from Professor Jorge Cortes
Georgia Cancer Center
Augusta University, Augusta (USA)

• Treatment-free remission as a new goal for patients with CML
  • Long-term follow-up data from the STIM study
  • Treatment strategies for patients with early and late relapse 
  • Biomarkers to predict a higher probability of relapse
  • Pharmacoeconomics of treatment discontinuation
• Complex genetics of CML - the work of the Genomics Alliance
• Clinical trial updates
  • SPIRIT trial
  • BEYOND study
  • Asciminib combinations
• Fatigue during TKI therapy

 {rscomments off}